期刊文献+

甲基强的松龙对脑损伤大鼠血清神经组织蛋白S100和神经元特异性烯醇化酶的影响 被引量:5

Effects of methylprednisolone on serum S-100B protein and neuron specific enolase in rats with brain injuries
原文传递
导出
摘要 目的通过比较血清神经组织蛋白S100(S-100B蛋白)和神经元特异性烯醇化酶(NSE)变化来观察甲基强的松龙对大鼠颅脑损伤的治疗作用。方法将72只SD大鼠随机分为3组,正常组8只,对照组和治疗组大鼠各32只,分为伤后1,6,12,24h4个小组,每小组8只,采用Feenery法造成鼠脑挫裂伤模型后,用酶联免疫检测技术定量检测伤后不同时相点血清S-100B蛋白和NSE水平。结果(1)正常组血清S-100B蛋白为(0.35±0.03)μg/L,NSE水平为(8.35±1.01)μg/L,对照组和治疗组伤后6~24h血清S-100B蛋白和NSE水平均比正常组高(P<0.05);(2)治疗组比对照组血清S-100B蛋白和NSE低(P<0.05)。结论甲基强的松龙对脑损伤有治疗作用。 Objective To observe the role of methylprednisolone in treatment of brain injuries through comparing the changes of serum S 100B protein and neuron specific enolase (NSE) levels. Methods Seventy two rats with brain contusion made by frontoparietal bone windows plasty with extradural hitting were divided into three groups: control group ( n =32), normal group ( n =8) and treatment group ( n =32) that were subdivided into groups 1, 6, 12 and 24 hours after injury. The levels of S 100B protein and NSE were measured at different time points after hitting by ELISA. Results ①The levels of serum S 100B protein and NSE was (0.35±0.03) μg/L and (8.35±1.01) μg/L, respectively in normal group. The levels of serum S 100 B protein and NSE in control group and treatment group (6 24 hours post injury) were higher than those in normal group ( P <0.05); ② The levels of serum S 100B protein and NSE in treatment group were lower than those in control group ( P <0.05). Conclusion Methylprednisolone is effective in treatment of brain injuries.
出处 《中华创伤杂志》 CAS CSCD 北大核心 2004年第11期671-673,共3页 Chinese Journal of Trauma
关键词 血清 S-100B蛋白 NSE 甲基强的松龙 大鼠 对照组 正常 小组 水平 结论 Brain injuries Phosphopyruvate hydratase Nerve tissue protein S100 Methylprednisolone
  • 相关文献

参考文献2

二级参考文献10

  • 1朱诚,江基尧.亚低温脑保护的研究和应用[J].中华创伤杂志,1997,13(1):1-3. 被引量:139
  • 2BakayRA,SweeneyKM,WoodJH.Pathophysiologyofcerebrospinalfluidinheadinjury.Part2.Biochemicalmarkersforcentralnervoussystemstrauma[J].Neurosurgery,1986,18(3):376-382.
  • 3HornM,SegerF,SchlotW.Neuron-specificenolaseingerbilbrainandserumaftertransientcerebralischemia[J].Stroke,1995,26(2):290-297.
  • 4HardemarkHG,EricssonN,KotwicaZ,etal.S-100proteinandneuron-specificenolaseincerebrospinalfluidafterexperimenttraumaticoffocalischemicbraindamage[J].JNeurosurg,1989,71(5):727-731.
  • 5HardemarkHG,PerssonL,BolanderH,etal.Neuron-specificenolaseisamarkerofcerebralischemiaandinfarctsizeinratcerebrospinalfluid[J].Stroke,1988,19(9):1140-1144.
  • 6BaroneFC,ClarkRK,PriceWJ,etal.Neuron-specificenolaseincreasesincerebralandsystemiccirculationfollowingfocalischemia[J].BrainRes,1993,623(1):77-82.
  • 7JohnssonP.Markersofcerebralischemiaaftercardiacsurgery[J].JCardiothoracVascAnesth,1996,10(1):120-126.
  • 8AurellA,RosengrenLE,KarissonB,etal.DeterminationofS-100andglialfibrillaryacidicproteinconcentrationsincerebrospinalfluidafterbraininfarction[J].Stroke,1991,22(10):1254-1258.
  • 9HatfieldRH,MckernanRM.CSFneuron-specificenolaseasaquantitativemarkerofneuronaldamageinaratstrokemodel[J].BrainRse,1992,577(2):249-252.
  • 10HenribeS,HilmarWP,ReiberH,etal.Neuronspecificenolaseconcentrationsinbloodasaprognosticparameterincerebrovasculardiseases[J].Stroke,1994,24(3):558-565.

共引文献39

同被引文献22

引证文献5

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部